Cell penetrating peptide-functionalized small interfering RNA nanoparticles knock down HER expression in breast cancer cells.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cell penetrating peptide-functionalized small interfering RNA nanoparticles knock down HER expression in breast cancer cells.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 392(12), 103697 (2025)
- Authors:
- Dissanayake, Ranga, Mishra, Vineet Kumar, Ahmed, Marya
- Database ID:
- RPEP-10735
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10735APA
Dissanayake, Ranga; Mishra, Vineet Kumar; Ahmed, Marya. (2025). Cell penetrating peptide-functionalized small interfering RNA nanoparticles knock down HER expression in breast cancer cells.. The Journal of pharmacology and experimental therapeutics, 392(12), 103697. https://doi.org/10.1016/j.jpet.2025.103697
MLA
Dissanayake, Ranga, et al. "Cell penetrating peptide-functionalized small interfering RNA nanoparticles knock down HER expression in breast cancer cells.." The Journal of pharmacology and experimental therapeutics, 2025. https://doi.org/10.1016/j.jpet.2025.103697
RethinkPeptides
RethinkPeptides Research Database. "Cell penetrating peptide-functionalized small interfering RN..." RPEP-10735. Retrieved from https://rethinkpeptides.com/research/dissanayake-2025-cell-penetrating-peptidefunctionalized-small
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.